Industry Research Reports

Home > Reports > Pharma & Healthcare > ADHD Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

ADHD Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 114 Pages

Report ld: 2636263

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Attention deficit and hyperactivity disorder (ADHD), commonly known as ADHD, refers to the occurrence of childhood,A group of syndromes characterized by marked difficulty concentrating, short attention span, hyperactivity, or impulsivity compared with children of the same age. To treat ADHD, the US FDA has approved two types of drugs: stimulants and non-stimulants. Stimulants include methylphenidate, amphetamines Amphetamine, non-stimulants including atomoxetine, guanfacine and clonidine.

The global market for ADHD Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for ADHD Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of ADHD Treatment by region & country, by Type, and by Application.

The ADHD Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADHD Treatment.

Market Segmentation

Report Metric
Details
Report Title
ADHD Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global ADHD Treatment Companies Covered
Takeda, Johnson & Johnson, N ovartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, N oven Pharmaceuticals, Purdue Parma, Jiangsu Chia Tai Fenghai Pharmaceutical
Global ADHD Treatment Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global ADHD Treatment Market, Segment by Type
Stimulant

Non-stimulant
Global ADHD Treatment Market, Segment by Application
Hospital Pharmacy

Retail Pharmacy
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of ADHD Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of ADHD Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of ADHD Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 ADHD Treatment Product Introduction
    1.2 Global ADHD Treatment Market Size Forecast
        1.2.1 Global ADHD Treatment Sales Value (2019-2030)
        1.2.2 Global ADHD Treatment Sales Volume (2019-2030)
        1.2.3 Global ADHD Treatment Sales Price (2019-2030)
    1.3 ADHD Treatment Market Trends & Drivers
        1.3.1 ADHD Treatment Industry Trends
        1.3.2 ADHD Treatment Market Drivers & Opportunity
        1.3.3 ADHD Treatment Market Challenges
        1.3.4 ADHD Treatment Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global ADHD Treatment Players Revenue Ranking (2023)
    2.2 Global ADHD Treatment Revenue by Company (2019-2024)
    2.3 Global ADHD Treatment Players Sales Volume Ranking (2023)
    2.4 Global ADHD Treatment Sales Volume by Company Players (2019-2024)
    2.5 Global ADHD Treatment Average Price by Company (2019-2024)
    2.6 Key Manufacturers ADHD Treatment Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers ADHD Treatment Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of ADHD Treatment
    2.9 ADHD Treatment Market Competitive Analysis
        2.9.1 ADHD Treatment Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by ADHD Treatment Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Treatment as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Stimulant
        3.1.2 Non-stimulant
    3.2 Global ADHD Treatment Sales Value by Type
        3.2.1 Global ADHD Treatment Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global ADHD Treatment Sales Value, by Type (2019-2030)
        3.2.3 Global ADHD Treatment Sales Value, by Type (%) (2019-2030)
    3.3 Global ADHD Treatment Sales Volume by Type
        3.3.1 Global ADHD Treatment Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global ADHD Treatment Sales Volume, by Type (2019-2030)
        3.3.3 Global ADHD Treatment Sales Volume, by Type (%) (2019-2030)
    3.4 Global ADHD Treatment Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital Pharmacy
        4.1.2 Retail Pharmacy
    4.2 Global ADHD Treatment Sales Value by Application
        4.2.1 Global ADHD Treatment Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global ADHD Treatment Sales Value, by Application (2019-2030)
        4.2.3 Global ADHD Treatment Sales Value, by Application (%) (2019-2030)
    4.3 Global ADHD Treatment Sales Volume by Application
        4.3.1 Global ADHD Treatment Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global ADHD Treatment Sales Volume, by Application (2019-2030)
        4.3.3 Global ADHD Treatment Sales Volume, by Application (%) (2019-2030)
    4.4 Global ADHD Treatment Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global ADHD Treatment Sales Value by Region
        5.1.1 Global ADHD Treatment Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global ADHD Treatment Sales Value by Region (2019-2024)
        5.1.3 Global ADHD Treatment Sales Value by Region (2025-2030)
        5.1.4 Global ADHD Treatment Sales Value by Region (%), (2019-2030)
    5.2 Global ADHD Treatment Sales Volume by Region
        5.2.1 Global ADHD Treatment Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global ADHD Treatment Sales Volume by Region (2019-2024)
        5.2.3 Global ADHD Treatment Sales Volume by Region (2025-2030)
        5.2.4 Global ADHD Treatment Sales Volume by Region (%), (2019-2030)
    5.3 Global ADHD Treatment Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America ADHD Treatment Sales Value, 2019-2030
        5.4.2 North America ADHD Treatment Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe ADHD Treatment Sales Value, 2019-2030
        5.5.2 Europe ADHD Treatment Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific ADHD Treatment Sales Value, 2019-2030
        5.6.2 Asia Pacific ADHD Treatment Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America ADHD Treatment Sales Value, 2019-2030
        5.7.2 South America ADHD Treatment Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa ADHD Treatment Sales Value, 2019-2030
        5.8.2 Middle East & Africa ADHD Treatment Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions ADHD Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions ADHD Treatment Sales Value
        6.2.1 Key Countries/Regions ADHD Treatment Sales Value, 2019-2030
        6.2.2 Key Countries/Regions ADHD Treatment Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States ADHD Treatment Sales Value, 2019-2030
        6.3.2 United States ADHD Treatment Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States ADHD Treatment Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe ADHD Treatment Sales Value, 2019-2030
        6.4.2 Europe ADHD Treatment Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe ADHD Treatment Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China ADHD Treatment Sales Value, 2019-2030
        6.5.2 China ADHD Treatment Sales Value by Type (%), 2023 VS 2030
        6.5.3 China ADHD Treatment Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan ADHD Treatment Sales Value, 2019-2030
        6.6.2 Japan ADHD Treatment Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan ADHD Treatment Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea ADHD Treatment Sales Value, 2019-2030
        6.7.2 South Korea ADHD Treatment Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea ADHD Treatment Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia ADHD Treatment Sales Value, 2019-2030
        6.8.2 Southeast Asia ADHD Treatment Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia ADHD Treatment Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India ADHD Treatment Sales Value, 2019-2030
        6.9.2 India ADHD Treatment Sales Value by Type (%), 2023 VS 2030
        6.9.3 India ADHD Treatment Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Takeda
        7.1.1 Takeda Company Information
        7.1.2 Takeda Introduction and Business Overview
        7.1.3 Takeda ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Takeda ADHD Treatment Product Offerings
        7.1.5 Takeda Recent Development
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Company Information
        7.2.2 Johnson & Johnson Introduction and Business Overview
        7.2.3 Johnson & Johnson ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Johnson & Johnson ADHD Treatment Product Offerings
        7.2.5 Johnson & Johnson Recent Development
    7.3 N ovartis
        7.3.1 N ovartis Company Information
        7.3.2 N ovartis Introduction and Business Overview
        7.3.3 N ovartis ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 N ovartis ADHD Treatment Product Offerings
        7.3.5 N ovartis Recent Development
    7.4 Eli Lilly
        7.4.1 Eli Lilly Company Information
        7.4.2 Eli Lilly Introduction and Business Overview
        7.4.3 Eli Lilly ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Eli Lilly ADHD Treatment Product Offerings
        7.4.5 Eli Lilly Recent Development
    7.5 Tris Pharma
        7.5.1 Tris Pharma Company Information
        7.5.2 Tris Pharma Introduction and Business Overview
        7.5.3 Tris Pharma ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Tris Pharma ADHD Treatment Product Offerings
        7.5.5 Tris Pharma Recent Development
    7.6 Neos Therapeutics
        7.6.1 Neos Therapeutics Company Information
        7.6.2 Neos Therapeutics Introduction and Business Overview
        7.6.3 Neos Therapeutics ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Neos Therapeutics ADHD Treatment Product Offerings
        7.6.5 Neos Therapeutics Recent Development
    7.7 Mallinckrodt
        7.7.1 Mallinckrodt Company Information
        7.7.2 Mallinckrodt Introduction and Business Overview
        7.7.3 Mallinckrodt ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Mallinckrodt ADHD Treatment Product Offerings
        7.7.5 Mallinckrodt Recent Development
    7.8 Amneal Pharmaceuticals
        7.8.1 Amneal Pharmaceuticals Company Information
        7.8.2 Amneal Pharmaceuticals Introduction and Business Overview
        7.8.3 Amneal Pharmaceuticals ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Amneal Pharmaceuticals ADHD Treatment Product Offerings
        7.8.5 Amneal Pharmaceuticals Recent Development
    7.9 N oven Pharmaceuticals
        7.9.1 N oven Pharmaceuticals Company Information
        7.9.2 N oven Pharmaceuticals Introduction and Business Overview
        7.9.3 N oven Pharmaceuticals ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 N oven Pharmaceuticals ADHD Treatment Product Offerings
        7.9.5 N oven Pharmaceuticals Recent Development
    7.10 Purdue Parma
        7.10.1 Purdue Parma Company Information
        7.10.2 Purdue Parma Introduction and Business Overview
        7.10.3 Purdue Parma ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Purdue Parma ADHD Treatment Product Offerings
        7.10.5 Purdue Parma Recent Development
    7.11 Jiangsu Chia Tai Fenghai Pharmaceutical
        7.11.1 Jiangsu Chia Tai Fenghai Pharmaceutical Company Information
        7.11.2 Jiangsu Chia Tai Fenghai Pharmaceutical Introduction and Business Overview
        7.11.3 Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Product Offerings
        7.11.5 Jiangsu Chia Tai Fenghai Pharmaceutical Recent Development

 8 Industry Chain Analysis
    8.1 ADHD Treatment Industrial Chain
    8.2 ADHD Treatment Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 ADHD Treatment Sales Model
        8.5.2 Sales Channel
        8.5.3 ADHD Treatment Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. ADHD Treatment Market Trends
    Table 2. ADHD Treatment Market Drivers & Opportunity
    Table 3. ADHD Treatment Market Challenges
    Table 4. ADHD Treatment Market Restraints
    Table 5. Global ADHD Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global ADHD Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Global ADHD Treatment Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global ADHD Treatment Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market ADHD Treatment Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers ADHD Treatment Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers ADHD Treatment Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of ADHD Treatment
    Table 13. Global ADHD Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Treatment as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global ADHD Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global ADHD Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global ADHD Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global ADHD Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global ADHD Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global ADHD Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global ADHD Treatment Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global ADHD Treatment Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global ADHD Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global ADHD Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global ADHD Treatment Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global ADHD Treatment Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global ADHD Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global ADHD Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global ADHD Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global ADHD Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global ADHD Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global ADHD Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global ADHD Treatment Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global ADHD Treatment Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global ADHD Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global ADHD Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global ADHD Treatment Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global ADHD Treatment Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global ADHD Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global ADHD Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global ADHD Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global ADHD Treatment Sales Value by Region (2019-2024) & (%)
    Table 44. Global ADHD Treatment Sales Value by Region (2025-2030) & (%)
    Table 45. Global ADHD Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global ADHD Treatment Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global ADHD Treatment Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global ADHD Treatment Sales Volume by Region (2019-2024) & (%)
    Table 49. Global ADHD Treatment Sales Volume by Region (2025-2030) & (%)
    Table 50. Global ADHD Treatment Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global ADHD Treatment Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions ADHD Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions ADHD Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions ADHD Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions ADHD Treatment Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions ADHD Treatment Sales Volume, (2025-2030) & (K Units)
    Table 57. Takeda Company Information
    Table 58. Takeda Introduction and Business Overview
    Table 59. Takeda ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Takeda ADHD Treatment Product Offerings
    Table 61. Takeda Recent Development
    Table 62. Johnson & Johnson Company Information
    Table 63. Johnson & Johnson Introduction and Business Overview
    Table 64. Johnson & Johnson ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Johnson & Johnson ADHD Treatment Product Offerings
    Table 66. Johnson & Johnson Recent Development
    Table 67. N ovartis Company Information
    Table 68. N ovartis Introduction and Business Overview
    Table 69. N ovartis ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. N ovartis ADHD Treatment Product Offerings
    Table 71. N ovartis Recent Development
    Table 72. Eli Lilly Company Information
    Table 73. Eli Lilly Introduction and Business Overview
    Table 74. Eli Lilly ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Eli Lilly ADHD Treatment Product Offerings
    Table 76. Eli Lilly Recent Development
    Table 77. Tris Pharma Company Information
    Table 78. Tris Pharma Introduction and Business Overview
    Table 79. Tris Pharma ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Tris Pharma ADHD Treatment Product Offerings
    Table 81. Tris Pharma Recent Development
    Table 82. Neos Therapeutics Company Information
    Table 83. Neos Therapeutics Introduction and Business Overview
    Table 84. Neos Therapeutics ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Neos Therapeutics ADHD Treatment Product Offerings
    Table 86. Neos Therapeutics Recent Development
    Table 87. Mallinckrodt Company Information
    Table 88. Mallinckrodt Introduction and Business Overview
    Table 89. Mallinckrodt ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Mallinckrodt ADHD Treatment Product Offerings
    Table 91. Mallinckrodt Recent Development
    Table 92. Amneal Pharmaceuticals Company Information
    Table 93. Amneal Pharmaceuticals Introduction and Business Overview
    Table 94. Amneal Pharmaceuticals ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Amneal Pharmaceuticals ADHD Treatment Product Offerings
    Table 96. Amneal Pharmaceuticals Recent Development
    Table 97. N oven Pharmaceuticals Company Information
    Table 98. N oven Pharmaceuticals Introduction and Business Overview
    Table 99. N oven Pharmaceuticals ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. N oven Pharmaceuticals ADHD Treatment Product Offerings
    Table 101. N oven Pharmaceuticals Recent Development
    Table 102. Purdue Parma Company Information
    Table 103. Purdue Parma Introduction and Business Overview
    Table 104. Purdue Parma ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Purdue Parma ADHD Treatment Product Offerings
    Table 106. Purdue Parma Recent Development
    Table 107. Jiangsu Chia Tai Fenghai Pharmaceutical Company Information
    Table 108. Jiangsu Chia Tai Fenghai Pharmaceutical Introduction and Business Overview
    Table 109. Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Product Offerings
    Table 111. Jiangsu Chia Tai Fenghai Pharmaceutical Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. ADHD Treatment Downstream Customers
    Table 115. ADHD Treatment Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. ADHD Treatment Product Picture
    Figure 2. Global ADHD Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global ADHD Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global ADHD Treatment Sales Volume (2019-2030) & (K Units)
    Figure 5. Global ADHD Treatment Sales Price (2019-2030) & (US$/Unit)
    Figure 6. ADHD Treatment Report Years Considered
    Figure 7. Global ADHD Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global ADHD Treatment Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by ADHD Treatment Revenue in 2023
    Figure 10. ADHD Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Stimulant Picture
    Figure 12. Non-stimulant Picture
    Figure 13. Global ADHD Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global ADHD Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global ADHD Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global ADHD Treatment Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global ADHD Treatment Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital Pharmacy
    Figure 19. Product Picture of Retail Pharmacy
    Figure 20. Global ADHD Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global ADHD Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global ADHD Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global ADHD Treatment Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global ADHD Treatment Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America ADHD Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America ADHD Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe ADHD Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe ADHD Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific ADHD Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific ADHD Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America ADHD Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America ADHD Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa ADHD Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa ADHD Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions ADHD Treatment Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions ADHD Treatment Sales Volume (%), (2019-2030)
    Figure 37. United States ADHD Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States ADHD Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States ADHD Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe ADHD Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe ADHD Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe ADHD Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 43. China ADHD Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China ADHD Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 45. China ADHD Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan ADHD Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan ADHD Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan ADHD Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea ADHD Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea ADHD Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea ADHD Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia ADHD Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia ADHD Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia ADHD Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 55. India ADHD Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India ADHD Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 57. India ADHD Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 58. ADHD Treatment Industrial Chain
    Figure 59. ADHD Treatment Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Description

Attention deficit and hyperactivity disorder (ADHD), commonly known as ADHD, refers to the occurrence of childhood,A group of syndromes characterized by marked difficulty concentrating, short attention span, hyperactivity, or impulsivity compared with children of the same age. To treat ADHD, the US FDA has approved two types of drugs: stimulants and non-stimulants. Stimulants include methylphenidate, amphetamines Amphetamine, non-stimulants including atomoxetine, guanfacine and clonidine.

The global market for ADHD Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Market Segmentation